In this study, we used paired-end sequencing of full-length mRNA transcripts to quantify and compare the effects of CDK4/6 inhibition and PRMT5 inhibition on gene expression and alternative RNA splicing within the CHL1 and A375 melanoma cell lines. The gene discussed is PRMT5; the disease is melanoma.